Neola Medical announces completion of patient enrollment in its clinical pilot study on preterm born babies in Sweden. All ten babies have now been included in the study, marking an important milestone with the first real-world use of Neola® in its target patient population in neonatal intensive care.
Key insights from the clinical pilot study will be communicated once the data has been analyzed and the final results are available.
Background
Neola Medical’s first clinical pilot study was conducted at the neonatal intensive care unit at Södra Älvsborgs Sjukhus in Borås, Sweden. The study is designed to evaluate the safety and performance of Neola® in continuous lung monitoring in preterm born babies. A total of 10 babies in neonatal intensive care with a gestational age from 28 weeks and a weight between 1000–3000 grams have been included.